Order Article Reprints

Haghmorad D, Yousefi B, Eslami M, Rashidy-Pour A, Tarahomi M, Tavaf MJ, Soltanmohammadi A, Zargarani S, Kamyshnyi A, Oksenych V. RETRACTED: Haghmorad et al. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Curr. Issues Mol. Biol. 2022, 44, 5728–5740. Current Issues in Molecular Biology. 2025; 47(9):781. https://doi.org/10.3390/cimb47090781

Haghmorad, Dariush, Bahman Yousefi, Majid Eslami, Ali Rashidy-Pour, Mahdieh Tarahomi, Maryam Jadid Tavaf, Azita Soltanmohammadi, Simin Zargarani, Aleksandr Kamyshnyi, and Valentyn Oksenych. 2025. "RETRACTED: Haghmorad et al. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Curr. Issues Mol. Biol. 2022, 44, 5728–5740" Current Issues in Molecular Biology 47, no. 9: 781. https://doi.org/10.3390/cimb47090781

Haghmorad, D., Yousefi, B., Eslami, M., Rashidy-Pour, A., Tarahomi, M., Tavaf, M. J., Soltanmohammadi, A., Zargarani, S., Kamyshnyi, A., & Oksenych, V. (2025). RETRACTED: Haghmorad et al. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Curr. Issues Mol. Biol. 2022, 44, 5728–5740. Current Issues in Molecular Biology, 47(9), 781. https://doi.org/10.3390/cimb47090781